Cross-sectional study shows higher NAFLD severity correlates with increased insulin resistance and dysglycemia.
Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome associated with insulin resistance and dysglycemia. This hospital-based cross-sectional study enrolled 104 ultrasound-confirmed NAFLD patients from a tertiary care center in India. NAFLD severity was graded ultrasonographically; insulin resistance was quantified using Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Insulin resistance was detected in 83.6%. Mean HOMA-IR increased across grades (3.31 ± 0.72, 4.51 ± 0.88, and 6.98 ± 0.42; P < 0.001). Glucose intolerance was present in 80.7%. Grade 3 NAFLD remained significantly associated with dysglycemia in adjusted exploratory analysis (adjusted odds ratio: 6.47, 95% confidence interval: 1.73–24.2, P = 0.005). These findings support routine glucose screening in NAFLD patients with higher ultrasound grades.
No takes yet. Share an insight, caveat, or question.
Medini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: